Leadership for systems change: Researcher practices for enhancing research impact in the prevention of chronic disease.

change chronic disease leadership prevention research research impact system

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 15 09 2022
accepted: 16 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Strengthening systems for chronic disease prevention is essential. Leadership for systems change is an important key to strengthening systems. Leadership in prevention research for supporting systems change remains a relatively abstract concept and there is limited empirical information about the leadership practices of prevention research teams when viewed through a complexity lens. In this paper we examine and describe some systems leadership practices for creating change through prevention research, as identified in a series of six case studies. A qualitative approach incorporating semi-structured interviews, participant observation, and document review was used to facilitate an in-depth investigation of the research topic. Several researcher practices for enhancing research impact in the prevention of chronic disease were distilled from the data pertaining to how they sought to create change. These included persuasive communication, compassion and deep listening, reflective practice, and embedding themselves within the systems they sought to change. The findings provide insights that may assist prevention researchers and other practitioners dedicated to creating change in chronic disease prevention.

Identifiants

pubmed: 36561852
doi: 10.3389/fpubh.2022.1045001
pmc: PMC9767460
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1045001

Informations de copyright

Copyright © 2022 Pescud, Rychetnik, Allender, Irving, Howse, Rutter, Ison, Riley, Friel and Finegood.

Déclaration de conflit d'intérêts

Authors MP, LR, MI, and EH were employed by The Australian Prevention Partnership Center. Author TR was employed by Therese Riley Consulting. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

BMC Public Health. 2019 Jun 11;19(1):729
pubmed: 31185993
Am J Community Psychol. 2012 Jun;49(3-4):503-16
pubmed: 21735334
PLoS Med. 2020 Jul 28;17(7):e1003198
pubmed: 32722671
Nature. 2013 Sep 12;501(7466):159-60
pubmed: 24032133
Lancet. 2020 Oct 17;396(10258):1135-1159
pubmed: 33069324
Health Care Manage Rev. 2000 Winter;25(1):83-92
pubmed: 10710732
J Psychiatr Res. 2020 Jul;126:134-140
pubmed: 31439359
Healthc Pap. 2011;11(2):31-7; discussion 64-7
pubmed: 21677515
Am J Community Psychol. 2007 Jun;39(3-4):197-215
pubmed: 17510791
Harv Bus Rev. 1999 Mar-Apr;77(2):64-74, 185
pubmed: 10387772
Implement Sci. 2007 Aug 28;2:28
pubmed: 17725834
Am J Public Health. 2014 Jul;104(7):1270-8
pubmed: 24832406
Nature. 2013 Nov 14;503(7475):167
pubmed: 24226852
Obes Rev. 2019 Nov;20 Suppl 2:179-184
pubmed: 31359617
BMC Public Health. 2020 Nov 17;20(1):1735
pubmed: 33203397

Auteurs

Melanie Pescud (M)

Menzies Centre for Health Governance, School of Regulation and Global Governance (RegNet), Australian National University, Canberra, ACT, Australia.
The Australian Prevention Partnership Centre, The Sax Institute, Glebe, NSW, Australia.

Lucie Rychetnik (L)

The Australian Prevention Partnership Centre, The Sax Institute, Glebe, NSW, Australia.
School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Steven Allender (S)

School of Health and Social Development, Faculty of Health, Deakin University, Geelong, VIC, Australia.

Michelle J Irving (MJ)

The Australian Prevention Partnership Centre, The Sax Institute, Glebe, NSW, Australia.
School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Centre for Evidence and Implementation, Carlton, VIC, Australia.

Eloise Howse (E)

The Australian Prevention Partnership Centre, The Sax Institute, Glebe, NSW, Australia.

Harry Rutter (H)

Department of Social and Policy Sciences, University of Bath, Bath, United Kingdom.

Ray Ison (R)

School of Engineering and Innovation, Faculty of Science, Technology, Engineering and Mathematics, The Open University, Milton Keynes, United Kingdom.

Therese Riley (T)

Therese Riley Consulting, Melbourne, VIC, Australia.
Mitchell Institute, Victoria University, Melbourne, VIC, Australia.

Sharon Friel (S)

Menzies Centre for Health Governance, School of Regulation and Global Governance (RegNet), Australian National University, Canberra, ACT, Australia.

Diane T Finegood (DT)

Morris J. Wosk Centre for Dialogue, Simon Fraser University, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH